IIRC News

Dr. Philip Greenberg elected to National Academy of Sciences

Dr. Philip Greenberg elected to National Academy of Sciences

Fred Hutch expert in immunology has led development of T-cell therapies for cancer
Hutch NewsMay 11, 2023
Improving immunotherapy for advanced prostate cancer

Improving immunotherapy for advanced prostate cancer

Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Hutch NewsApril 27, 2023
Immunotherapy helps retired fisheries biologist get back to normal

Immunotherapy helps retired fisheries biologist get back to normal

Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Hutch NewsMarch 13, 2023
Award will fund research into new metastatic prostate cancer therapies

Award will fund research into new metastatic prostate cancer therapies

Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Hutch NewsOctober 21, 2022
New approach could make bone marrow transplantation safer, stronger

New approach could make bone marrow transplantation safer, stronger

Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Hutch NewsOctober 14, 2022
Making immunotherapy more effective against small cell lung cancer

Making immunotherapy more effective against small cell lung cancer

Human trial opens after experimental drug improves tumor growth suppression in mice
Hutch NewsAugust 03, 2022
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch NewsDecember 18, 2020
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Hutch NewsNovember 16, 2020
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results

Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results

'Practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
Hutch NewsSeptember 18, 2020